CAN
JAZZ icon

Cetera Advisor Networks’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cetera Advisor Networks’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-7,774
Closed -$956K – 2868
2023
Q4 		$956K Buy
7,774
+5,400
+227% +$674K 0.01% 1408
2023
Q3 		$307K Buy
2,374
+495
+26% +$66K ﹤0.01% 2131
2023
Q2 		$233K Buy
1,879
+21
+1% +$2.83K ﹤0.01% 2246
2023
Q1 		$272K Buy
1,858
+64
+4% +$9.47K ﹤0.01% 2112
2022
Q4 		$286K Buy
+1,794
New +$263K ﹤0.01% 2028
2020
Q3 		– Sell
-50
Closed -$6K – 2140
2020
Q2 		$6K Buy
+50
New +$5.53K ﹤0.01% 2919

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Cetera Advisor Networks's JAZZ Position: Q1 2024 in Review

Cetera Advisor Networks sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 7,774 shares — an estimated $956K sold.

Cetera Advisor Networks first reported a position in JAZZ in Q2 2020 and held it in 6 quarters. The position peaked at $956K in Q4 2023. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Cetera Advisor Networks reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 7,774 Jazz Pharmaceuticals shares in Q1 2024, an estimated $956K.
  • Cetera Advisor Networks first reported a position in Jazz Pharmaceuticals in Q2 2020 and held it in 6 quarters.
  • Cetera Advisor Networks's Jazz Pharmaceuticals position peaked at $956K in Q4 2023.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.